To study whether those tumors would be responsive to anti-PD1 therapy, idMMR 14-week neuroblastoma cells were inoculated in immunocompetent mice and treated with either isotype control or anti-PD1 therapy. The gene discussed is PDCD1; the disease is neuroblastoma.